Literature DB >> 24030835

Sclerostin in CKD-MBD: one more paradoxical bone protein?

Guillaume Jean1, Charles Chazot.   

Abstract

Entities:  

Keywords:  bone disease; bone marker; kidney disease; sclerostin; survival

Mesh：

Substances：

Year:  2013        PMID： 24030835     DOI： 10.1093/ndt/gft222

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.

Authors:  Y Asamiya; A Yajima; S Shimizu; S Otsubo; K Tsuchiya; K Nitta
Journal:  Osteoporos Int       Date:  2014-11-04       Impact factor: 4.507

2.  Sclerostin in Excessive Drinkers: Relationships with Liver Function and Body Composition.

Authors:  Candelaria Martín González; Camino María Fernández Rodríguez; Pedro Abreu González; Alen García Rodríguez; Julio César Alvisa Negrín; Elisa Cabañas Perales; Lourdes González Navarrete; Víctor Eugenio Vera Delgado; Paula Ortega Toledo; Emilio González Reimers
Journal:  Nutrients       Date:  2022-06-22       Impact factor: 6.706

3.  Improvement of Mineral and Bone Disorders After Renal Transplantation.

Authors:  Ana Carina Ferreira; Marco Mendes; Cecília Silva; Patrícia Cotovio; Inês Aires; David Navarro; Fernando Caeiro; Rúben Ramos; Rute Salvador; Bruna Correia; Guadalupe Cabral; Fernando Nolasco; Aníbal Ferreira
Journal:  Transplantation       Date:  2022-03-08       Impact factor: 5.385

4.  Physical performance and protein-energy wasting in patients treated with nocturnal haemodialysis compared to conventional haemodialysis: protocol of the DiapriFIT study.

Authors:  Manouk Dam; Floor Neelemaat; Trudeke Struijk-Wielinga; Peter J Weijs; Brigit C van Jaarsveld
Journal:  BMC Nephrol       Date:  2017-05-01       Impact factor: 2.388

5.  Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.

Authors:  Alper Kirkpantur; Mustafa Balci; Aysel Turkvatan; Baris Afsar
Journal:  Clin Kidney J       Date:  2015-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.